{"id":55307,"date":"2025-11-26T17:34:37","date_gmt":"2025-11-26T12:04:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=55307"},"modified":"2025-11-26T17:35:11","modified_gmt":"2025-11-26T12:05:11","slug":"invicta-diagnostic-ipo-gmp","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/","title":{"rendered":"Invicta Diagnostic IPO GMP &#038; Review: Apply or Avoid?"},"content":{"rendered":"<p><strong>The Invicta Diagnostic IPO<\/strong> is open for bidding from 1st December 2025 to 3rd December 2025. It is a bookbuilding IPO of \u20b928.12 crore and entirely a fresh issue worth \u20b933,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 8th December 2025.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_IPO_Details\" title=\"Invicta Diagnostic IPO Details&nbsp;\">Invicta Diagnostic IPO Details&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_IPO_Share_Reservation\" title=\"Invicta Diagnostic IPO Share Reservation\">Invicta Diagnostic IPO Share Reservation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_IPO_GMP_Grey_Market_Premium\" title=\"Invicta Diagnostic IPO GMP Grey Market Premium\">Invicta Diagnostic IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_IPO_GMP_Review\" title=\"Invicta Diagnostic IPO GMP Review\">Invicta Diagnostic IPO GMP Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Financial_Health\" title=\"Financial Health\">Financial Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Technical_Analysis\" title=\"Technical Analysis\">Technical Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_IPO_Subscription_Status\" title=\"Invicta Diagnostic IPO Subscription Status\">Invicta Diagnostic IPO Subscription Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#About_Invicta_Diagnostic_Limited\" title=\"About Invicta Diagnostic Limited\">About Invicta Diagnostic Limited<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_Limited_Financials\" title=\"Invicta Diagnostic&nbsp; Limited Financials\">Invicta Diagnostic&nbsp; Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_IPO_Bidding_Requirements\" title=\"Invicta Diagnostic IPO Bidding Requirements\">Invicta Diagnostic IPO Bidding Requirements<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Invicta_Diagnostic_Limited_IPO_Promoter_Holdings\" title=\"Invicta Diagnostic&nbsp; Limited IPO Promoter Holdings\">Invicta Diagnostic&nbsp; Limited IPO Promoter Holdings<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Aim_of_Invicta_Diagnostic_IPO\" title=\"Aim of Invicta Diagnostic IPO\">Aim of Invicta Diagnostic IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Should_I_Invest_in_the_Invicta_Diagnostic_IPO\" title=\"Should I Invest in the Invicta Diagnostic IPO?\">Should I Invest in the Invicta Diagnostic IPO?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Pros_of_the_Invicta_Diagnostic_IPO\" title=\"Pros of the Invicta Diagnostic IPO\">Pros of the Invicta Diagnostic IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Cons_of_the_Invicta_Diagnostic_IPO\" title=\"Cons of the Invicta Diagnostic\u00a0 IPO\">Cons of the Invicta Diagnostic\u00a0 IPO<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#How_to_Apply_for_Invicta_Diagnostic_IPO\" title=\"How to Apply for Invicta Diagnostic IPO?\">How to Apply for Invicta Diagnostic IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#How_to_Check_Invicta_Diagnostic_IPO_Allotment_Status\" title=\"How to Check Invicta Diagnostic IPO Allotment Status?\">How to Check Invicta Diagnostic IPO Allotment Status?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Check_On_NSE\" title=\"Check On NSE\">Check On NSE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Check_On_the_Registrar_Portal\" title=\"Check On the Registrar Portal\">Check On the Registrar Portal<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Lets_Wrap\" title=\"Let\u2019s Wrap\">Let\u2019s Wrap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#FAQs_on_Invicta_Diagnostic_IPO\" title=\"FAQs on Invicta Diagnostic IPO\">FAQs on Invicta Diagnostic IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#How_is_the_Invicta_Diagnostic_IPO\" title=\"How is the Invicta Diagnostic IPO?\">How is the Invicta Diagnostic IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#What_is_the_Invicta_Diagnostic_IPO_price\" title=\"What is the Invicta Diagnostic IPO price?\">What is the Invicta Diagnostic IPO price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Is_the_Invicta_Diagnostic_IPO_good\" title=\"Is the Invicta Diagnostic IPO good?\">Is the Invicta Diagnostic IPO good?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Who_is_the_registrar_of_the_Invicta_Diagnostic_IPO\" title=\"Who is the registrar of the Invicta Diagnostic IPO?\">Who is the registrar of the Invicta Diagnostic IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#What_is_the_issue_size_of_the_Invicta_Diagnostic_IPO\" title=\"What is the issue size of the Invicta Diagnostic IPO?&nbsp;\">What is the issue size of the Invicta Diagnostic IPO?&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Upcoming_IPOs\" title=\"Upcoming IPOs\">Upcoming IPOs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Current_Previous_IPOs\" title=\"Current &amp; Previous IPOs\">Current &amp; Previous IPOs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Read_Our_Articles_on_the_Best_Stocks\" title=\"Read Our Articles on the Best Stocks\">Read Our Articles on the Best Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Also_Explore\" title=\"Also Explore\">Also Explore<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Univest_Screeners\" title=\"Univest Screeners\">Univest Screeners<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/univest.in\/blogs-2\/invicta-diagnostic-ipo-gmp\/#Explore_Webstories_on_Univest\" title=\"Explore Webstories on Univest&nbsp;\">Explore Webstories on Univest&nbsp;<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Details\"><\/span><strong>Invicta Diagnostic IPO Details&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The <strong>Invicta Diagnostic IPO<\/strong> date is fixed between 1st December 2025 and 3rd December 2025. The face value of Invicta Diagnostic shares stands at \u20b910 per share, and the IPO Issue price band is set at \u20b980 to \u20b985 per share<\/p><p>Bigshare Services Private Limited is the registrar of the <strong>Invicta Diagnostic IPO <\/strong>and is responsible for managing the allotment process and initiating refunds. Check out the latest <a href=\"https:\/\/univest.in\/blogs\/what-is-an-ipo\">IPO<\/a> details in the table below.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>4th December 2025<\/td><\/tr><tr><td><strong>IPO Open Date<\/strong><\/td><td>1st December 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>3rd December 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>5th December 2025<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>33,08,800 shares(aggregating up to \u20b928.12 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,600 shares<\/td><\/tr><tr><td><strong>Issue Price&nbsp;<\/strong><\/td><td>\u20b980 to \u20b985 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>NSE SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>8th December 2025<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Share_Reservation\"><\/span><strong>Invicta Diagnostic IPO Share Reservation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>Invicta Diagnostic IPO <\/strong>is a bookbuilding IPO issue of 33,00,000 shares worth \u20b928.12 crores. Invicta Diagnostic IPO Limited shares will be listed on the BSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Investor Categories<\/strong><\/td><td><strong>Shares Offered<\/strong><\/td><\/tr><tr><td><strong>QIB shares offered<\/strong><\/td><td>Not more than 50% of the Net Issue<\/td><\/tr><tr><td><strong>NII (HNI) Shares Offered<\/strong><\/td><td>Not less than 15% of the Net Issue<\/td><\/tr><tr><td><strong>Retail Shares Offered<\/strong><\/td><td>Not less than 35% of the Net Issue<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Invicta Diagnostic IPO GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the <strong>Invicta Diagnostic IPO<\/strong>? If yes, then you\u2019ve reached the right spot. Check the table below to learn about the GMP trends.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP DATE<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP Price<\/strong><\/td><td><strong>Estimated Listing Price<\/strong><\/td><td><strong>Estimated Gain<\/strong><\/td><\/tr><tr><td><strong>2-12-2025<\/strong><\/td><td>&#8211;<\/td><td>&#8211;<\/td><td>&#8211;<\/td><td><strong>&#8211;<\/strong><\/td><\/tr><tr><td><strong>1-12-2025<\/strong><\/td><td>&#8211;<\/td><td>&#8211;<\/td><td>&#8211;<\/td><td><strong>&#8211;<\/strong><\/td><\/tr><tr><td><strong>30-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>29-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>28-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>27-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>26-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>25-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>24-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>23-11-2025<\/strong><\/td><td>\u20b985.00<\/td><td>\u20b90.00<\/td><td>\u20b985.00<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><p>As of 1st December 2025, <strong>Invicta Diagnostic IPO GMP<\/strong> stands at \u20b90 per share, which means the share will likely show a listing at \u20b985 on its tentative listing date, 8th December 2025.<\/p><p>GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the <strong>Invicta Diagnostic IPO GMP<\/strong>. Stay informed with Univest for real-time insights into IPOs and their GMP trends.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_GMP_Review\"><\/span><strong>Invicta Diagnostic IPO GMP Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-1024x536.jpg\" alt=\"Invicta Diagnostic IPO Review \n\" class=\"wp-image-55309\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Check out the detailed <strong>Invicta Diagnostic GMP IPO <\/strong>review<strong> <\/strong>for a thorough understanding of its potential to report listing gains on 8th December 2025. The Invicta Diagnostic IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Financial_Health\"><\/span><strong>Financial Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Assess a company&#8217;s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business&#8217;s economic growth and decline before applying for the Invicta Diagnostic IPO.<\/p><p>Invicta Diagnostic&nbsp; Limited&#8217;s revenue soared by 90% from \u20b915.90 crores in March 2024&nbsp; to \u20b930.18 crores in March 2025. Moreover, the company&#8217;s PAT increased by 30% from \u20b93.81 crores in March 2024 to \u20b94.93 crores in March 2025.<\/p><p>Invicta Diagnostic&nbsp; Ipo<strong> <\/strong>has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for the <strong>Invicta Diagnostic IPO <\/strong>for its tentative listing day, which is 8th December 2025.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Analysis\"><\/span><strong>Technical Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Several technical indicators are available to assess a company&#8217;s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the <strong>Invicta Diagnostic IPO<\/strong>.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)&nbsp;<\/strong><\/a><\/td><td>15.97<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>5.32<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>36.25%<\/td><\/tr><tr><td><strong>ROCE<\/strong><\/td><td>42.00%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>44.28%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>30.57%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>5.26<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9106.86 Cr.<\/td><\/tr><\/tbody><\/table><\/figure><p>The PE ratio of Invicta Diagnostic Limited shares is 15.97, and its Earnings Per Share (EPS) stands at 5.32. Thus, the <strong>Invicta Diagnostic IPO<\/strong> can potentially deliver gains on its tentative listing date, 8th December 2025.&nbsp;<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Invicta Diagnostic&nbsp; Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>15.97<\/td><td>13.08<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>5.32<\/td><td>13.08<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Subscription_Status\"><\/span><strong>Invicta Diagnostic IPO Subscription Status<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>The Invicta Diagnostic IPO<\/strong> is to be opened for bidding on 1st December 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Invicta Diagnostic IPO Subscription Status.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Investor Category<\/strong><\/td><td><strong>Shares Offered<\/strong><\/td><td><strong>Shares Subscribed<\/strong><\/td><td><strong>Subscription to the Times<\/strong><\/td><\/tr><tr><td><strong>QIB shares offered<\/strong><\/td><td>Not more than 50% of the Net Issue<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><tr><td><strong>NII (HNI) Shares Offered<\/strong><\/td><td>Not less than 15% of the Net Issue<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><tr><td><strong>Retail Shares Offered<\/strong><\/td><td>Not less than 35% of the Net Issue<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Invicta_Diagnostic_Limited\"><\/span><strong>About Invicta Diagnostic Limited<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-1024x536.jpg\" alt=\"Invicta Diagnostic IPO Limited\" class=\"wp-image-55310\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Invicta Diagnostics was established in January 2021. Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand &#8216;PC Diagnostics&#8217; through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra. Invicta Diagnostics\u202fLimited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub\u2011and\u2011spoke model across the Mumbai Metropolitan Region, featuring:<\/p><ol class=\"wp-block-list\"><li>Flagship Hub<\/li>\n\n<li>Three additional hubs are Bhayandar, Byculla, and Marol<\/li>\n\n<li>Three spokes in Lower Parel, Sewri and Kalwa<\/li><\/ol><p>The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_Financials\"><\/span><strong>Invicta Diagnostic&nbsp; Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the<strong> Invicta Diagnostic IPO. <\/strong>Look at the table to learn about Invicta Diagnostic&nbsp; Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>30th September 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>34.90<\/td><td>21.22<\/td><td>15.89<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>17.08<\/td><td>30.18<\/td><td>15.90<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>4.08<\/td><td>4.93<\/td><td>3.81<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>6.77<\/td><td>9.20<\/td><td>7.09<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>23.68<\/td><td>13.60<\/td><td>8.67<\/td><\/tr><tr><td><strong>Reserves and Surplus<\/strong><\/td><td>14.42<\/td><td>5.18<\/td><td>8.54<\/td><\/tr><tr><td><strong>Total Borrowing<\/strong><\/td><td>3.72<\/td><td>3.54<\/td><td>3.81<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Invicta Diagnostic&nbsp; Limited&#8217;s revenue soared by 90% from \u20b915.90 crores in March 2024&nbsp; to \u20b930.18 crores in March 2025. Moreover, the company&#8217;s PAT increased by 30% from \u20b93.81 crores in March 2024 to \u20b94.93 crores in March 2025.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_IPO_Bidding_Requirements\"><\/span><strong>Invicta Diagnostic IPO Bidding Requirements<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Investors can bid for a Minimum of 3,200 shares in multiples of 1,600 Shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Application&nbsp;<\/strong><\/td><td><strong>Lots&nbsp;<\/strong><\/td><td><strong>Shares&nbsp;<\/strong><\/td><td><strong>Amount<\/strong><\/td><\/tr><tr><td><strong>Individual Investors (Retail) (Min)<\/strong><\/td><td>2<\/td><td>3,200<\/td><td>\u20b92,72,000<\/td><\/tr><tr><td><strong>Individual Investors (Retail) (Max)<\/strong><\/td><td>2<\/td><td>3,200<\/td><td>\u20b92,72,000<\/td><\/tr><tr><td><strong>S-HNI (Min)<\/strong><\/td><td>3<\/td><td>4,800<\/td><td>\u20b94,08,000<\/td><\/tr><tr><td><strong>S-HNI (Max)<\/strong><\/td><td>7<\/td><td>11,200<\/td><td>\u20b99,52,000<\/td><\/tr><tr><td><strong>B-HNI (Min)<\/strong><\/td><td>8<\/td><td>12,800<\/td><td>\u20b910,88,000<\/td><\/tr><\/tbody><\/table><\/figure><p><strong>The Invicta Diagnostic IPO<\/strong> has reserved lot sizes to be applied by different investor categories. Look at the table below to know about the requirements to be fulfilled for applying for this IPO.<\/p><p><em>Use the lot size calculator to find how many shares you should apply!<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_IPO_Promoter_Holdings\"><\/span><strong>Invicta Diagnostic&nbsp; Limited IPO Promoter Holdings<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Have a look at the table below to check the holdings of Invicta Diagnostic Limited. Dr Ketan Jayantilal Jain, Dr Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi and Jayesh Prakash Jain are the promoters of the company.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Shareholding Pre-Issue<\/strong><\/td><td>90.52%<\/td><\/tr><tr><td><strong>Shareholding Post-Issue<\/strong><\/td><td><\/td><\/tr><\/tbody><\/table><\/figure><p><strong><em>Note<\/em><\/strong><em>: <\/em><em>The value will be calculated using Equity Dilution = Share Holding Pre Issue &#8211; Share Holding Post Issue<\/em><em>.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aim_of_Invicta_Diagnostic_IPO\"><\/span><strong>Aim of Invicta Diagnostic IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Invicta Diagnostic IPO<\/strong> is to raise \u20b928.12 crores. On the other hand, Invicta Diagnostic has decided to utilise these funds in different ways. Explore some of the secondary objectives for the <strong>Invicta Diagnostic IPO<\/strong>.<\/p><ul class=\"wp-block-list\"><li>Funding capital expenditure for the purchase of medical equipment towards the establishment of five new diagnostic centres in Maharashtra<\/li>\n\n<li>General Corporate purposes<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Should_I_Invest_in_the_Invicta_Diagnostic_IPO\"><\/span><strong>Should I Invest in the Invicta Diagnostic IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><em>MSECL is one of the leading comprehensive consultancy service providers with all related aspects. It marked growth in its top and bottom lines for the reported periods. It can generate higher margins because of its capability to provide all related services under one roof. Based on recent financial data, the issue appears reasonably priced. Investors may park funds for medium- to long-term investments. <\/em>~Dilip Davda (Chief Editor at Chittorgarh)<\/p><p>Explore the pros and cons of the Invicta Diagnostic to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO\u2019s efficiency in delivering profits in the coming decades.&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Pros_of_the_Invicta_Diagnostic_IPO\"><\/span><strong>Pros of the Invicta Diagnostic IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ol class=\"wp-block-list\"><li>The company has an expanding presence in the Mumbai Metropolitan region, especially in radiology.<\/li>\n\n<li>The company has technical capabilities and technology, including an IT infrastructure.<\/li>\n\n<li>The company is a dedicated management team with significant industry experience.<\/li><\/ol><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cons_of_the_Invicta_Diagnostic_IPO\"><\/span><strong>Cons of the Invicta Diagnostic\u00a0 IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ol class=\"wp-block-list\"><li>The company has a high dependence on radiology\u00a0<\/li>\n\n<li>The company has operational risks and a single hub dependence\u00a0<\/li>\n\n<li>The company has geographic concentration risk<\/li><\/ol><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_to_Apply_for_Invicta_Diagnostic_IPO\"><\/span><strong>How to Apply for Invicta Diagnostic IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-1024x536.jpg\" alt=\"\" class=\"wp-image-55311\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Follow the steps below to apply for Invicta Diagnostic Ltd.<\/p><ul class=\"wp-block-list\"><li><strong>Step 1<\/strong>: Conduct thorough research on the Invicta Diagnostic IPO GMP, subscription status, issue size, lot size, and other details.\u00a0<\/li>\n\n<li><strong>Step 2<\/strong>: Open a <a href=\"https:\/\/univest.in\/blogs\/demat-account\"><strong>demat account on Univest<\/strong><\/a> to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section.\u00a0<\/li>\n\n<li><strong>Step 3<\/strong>: Make a bid for two lots of 3,200 shares worth \u20b92,72,000<\/li>\n\n<li><strong>Step 4<\/strong>: You will receive a mandate request after making a bid. Approve the request to proceed further.\u00a0\u00a0\u00a0\u00a0<\/li><\/ul><p><strong><em>Note<\/em><\/strong><em>: You can apply for the Invicta Diagnostic IPO from more than one demat account to increase your allotment chances.&nbsp;<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_to_Check_Invicta_Diagnostic_IPO_Allotment_Status\"><\/span><strong>How to Check Invicta Diagnostic IPO Allotment Status?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>You can check for the Invicta Diagnostic IPO allotment in different ways. These include BSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Check_On_NSE\"><\/span><strong><\/strong><strong>Check On NSE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>Visit the <a href=\"https:\/\/www.nseindia.com\/\" rel=\"nofollow noopener\" target=\"_blank\"><strong>NSE Official Site<\/strong><\/a><\/li>\n\n<li>Navigate to the IPO Allotment Section.\u00a0<\/li>\n\n<li>Select Equity as the issue type.\u00a0<\/li>\n\n<li>Choose the Invicta Diagnostic <strong>IPO<\/strong>.\u00a0\u00a0<\/li>\n\n<li>Choose whether to proceed with the PAN number or the application number.<\/li>\n\n<li>Submit your details to get the allotment status online.\u00a0<\/li><\/ul><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Check_On_the_Registrar_Portal\"><\/span><strong><\/strong><strong>Check On the Registrar Portal<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>Visit the <a href=\"https:\/\/ipo.bigshareonline.com\/IPO_Status.html\" rel=\"nofollow noopener\" target=\"_blank\"><strong>registrar portal<\/strong><\/a>.<\/li>\n\n<li>Click on the allotment option.<\/li>\n\n<li>Fill in the required details.<\/li>\n\n<li>Click on the submit button to know your<strong> Invicta Diagnostic IPO<\/strong> allotment status.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Lets_Wrap\"><\/span><strong>Let\u2019s Wrap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>The Invicta Diagnostic IPO <\/strong>is a bookbuilding issue of shares worth \u20b928.12 crores. The shares of Invicta Diagnostic&nbsp; Limited will be listed on BSE and SME on its tentative listing date of 8th December 2025. Researching the Invicta Diagnostic IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.<\/p><p><strong><em>Open a demat account on Univest now to initiate your investment journey!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Invicta_Diagnostic_IPO\"><\/span><strong>FAQs on Invicta Diagnostic IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_is_the_Invicta_Diagnostic_IPO\"><\/span><strong>How is the Invicta Diagnostic IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Currently, on 1st December 2025, the <strong>Invicta Diagnostic GMP<\/strong> (Grey Market Premium) stands at \u20b90. It indicates that the estimated listing price could be \u20b985 per share. It is a bookbuilding IPO of 33.00 lakh shares worth \u20b928.12 crores. The face value of each Invicta Diagnostic share is \u20b910.&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Invicta_Diagnostic_IPO_price\"><\/span><strong>What is the Invicta Diagnostic IPO price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. The <strong>Invicta Diagnostic IPO<\/strong> issue price band is set at \u20b980 to \u20b985 per share. Retail investors can apply for a minimum of 2 lots consisting of 3,200 shares worth \u20b92,72,000. Moreover, HNIs are required to bid for a minimum of 3 lots (4,800 shares) worth \u20b94,08,000.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_the_Invicta_Diagnostic_IPO_good\"><\/span><strong>Is the Invicta Diagnostic IPO good?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Invicta Diagnostic&nbsp; Limited&#8217;s revenue soared by 90% from \u20b915.90 crores in March 2024&nbsp; to \u20b930.18 crores in March 2025. Moreover, the company&#8217;s PAT increased by 30% from \u20b93.81 crores in March 2024 to \u20b94.93 crores in March 2025.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_the_Invicta_Diagnostic_IPO\"><\/span><strong>Who is the registrar of the Invicta Diagnostic IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans.&nbsp; Bigshare Services Pvt Limited is the registrar for the <strong>Invicta Diagnostic IPO,<\/strong> awaiting to manage the allotment process and initiate refunds. For any queries regarding the Invicta Diagnostic allotment and refund, you can contact Bigshare Services Pvt. Ltd. at <a href=\"mailto:ipo@bigshareonline.com\">ipo@bigshareonline.com<\/a> or +91-22-6263 8200.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_size_of_the_Invicta_Diagnostic_IPO\"><\/span><strong>What is the issue size of the Invicta Diagnostic IPO?&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. <strong>Invicta Diagnostic IPO<\/strong> is a bookbuilding IPO for 33.00 lakh shares worth \u20b928.12 crore. Moreover, the IPO is set to open on 1st December 2025 and will be closed on 3rd December 2025.&nbsp;<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Invicta Diagnostic IPO, download the Invicta Diagnostic IPO RHP and Invicta Diagnostic IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Upcoming_IPOs\"><\/span><strong>Upcoming IPOs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Names<\/strong><\/td><td><strong>Expected Year of IPO<\/strong><\/td><\/tr><tr><td><strong>PhonePe IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>Bajaj Energy IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>OYO IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>NSDL IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>Flipkart IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>Zepto IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>boAt IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>Meesho IPO<\/strong><\/td><td>2025<\/td><\/tr><tr><td><strong>Jio IPO<\/strong><\/td><td>2026<\/td><\/tr><tr><td><strong>NSE IPO<\/strong><\/td><td>2025<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Current_Previous_IPOs\"><\/span><strong>Current &amp; Previous IPOs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Company<\/strong><\/td><td><strong>IPO Open<\/strong><\/td><td><strong>IPO Close<\/strong><\/td><td><strong>Type<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/anthem-biosciences-ipo\">Anthem Biosciences Limited<\/a><\/td><td>14th July 2025<\/td><td>16th July 2025<\/td><td>Mainboard<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/spunweb-nonwoven-ipo\">Spunweb Nonwoven Limited<\/a><\/td><td>14th July 2025<\/td><td>16th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/smartworks-coworking-spaces-ipo\">Smartworks Coworking Spaces Limited<\/a><\/td><td>10th July 2025<\/td><td>14th July 2025<\/td><td>Mainboard<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/stocks\/cff\/cff-fluid-control-ltd-share-price-today\">CFF Fluid Control Limited<\/a><\/td><td>9th July 2025<\/td><td>11th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/stocks\/glen\/glen-industries-limited-share-price-today\">GLEN Industries Limited<\/a><\/td><td>8th July 2025<\/td><td>10th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/stocks\/chemkart\/chemkart-india-limited-share-price-today\">Chemkart India Limited<\/a><\/td><td>7th July 2025<\/td><td>9th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/travel-food-services-ipo-listing\">Travel Food Services Limited<\/a><\/td><td>7th July 2025<\/td><td>9th July 2025<\/td><td>Mainboard<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/smarten-power-systems-ipo\">Smarten Power Systems Limited<\/a><\/td><td>7th July 2025<\/td><td>9th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/meta-infotech-ipo\">Meta Infotech Limited<\/a><\/td><td>4th July 2025<\/td><td>8th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/cryogenic-ogs-ipo-review-apply-or-avoid\">Cryogenic OGS Limited<\/a><\/td><td>3rd July 2025<\/td><td>7th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/white-force-ipo\">Happy Square Outsourcing Services Limited<\/a><\/td><td>3rd July 2025<\/td><td>7th July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/crizac-ipo-review-apply-or-avoid\">Crizac Limited<\/a><\/td><td>3rd July 2025<\/td><td>7th July 2025<\/td><td>Mainboard<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/silky-overseas-ipo\">Silky Overseas Limited<\/a><\/td><td>30th June 2025<\/td><td>2nd July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/pushpa-jewellers-ipo\">Pushpa Jewellers Limited<\/a><\/td><td>30th June 2025<\/td><td>2nd July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/cedaar-textile-ipo-gmp\">Cedaar Textile Limited<\/a><\/td><td>30th June 2025<\/td><td>2nd July 2025<\/td><td>SME<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/marc-loire-fashions-ipo\">Marc Loire Fashions Limited<\/a><\/td><td>30th June 2025<\/td><td>2nd July 2025<\/td><td>SME<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Read_Our_Articles_on_the_Best_Stocks\"><\/span><strong>Read Our Articles on the Best Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/tech-stocks\">Tech Stocks in India to Invest in 2025 | Tech Sector Stocks&nbsp;<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/battery-stocks\">Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/shipping-stocks\">Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/paint-stocks\">Paint Stocks in India to Invest in 2025 | Paint Sector Stocks<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/paper-stocks\">Paper Stocks in India to Invest in 2025 | Paper Sector Stocks&nbsp;<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/semiconductor-stocks-in-india\">Best Semiconductor Stocks in India 2025<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/large-cap-stocks\">Best Large Cap Stocks in India 2025&nbsp;<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/green-energy-penny-stocks\">Green Energy Penny Stocks<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/cement-stocks\">Best Cement Stocks To Invest In India<\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Also_Explore\"><\/span><strong>Also Explore<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Best Stocks&nbsp;<\/strong><\/td><td><strong>Multibagger Stocks&nbsp;<\/strong><\/td><td><strong>Penny Stocks<\/strong><\/td><td><strong>Fundamentally Strong Stocks&nbsp;<\/strong><\/td><td><strong>Sector-Wise Stocks<\/strong><\/td><td><strong>PSU \/Government Stocks<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-indian-stocks-for-next-10-years\">For the Next 10 Years<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-stocks-for-next-5-years\">For the Next 5 Years<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/solar-penny-stocks\">Solar Penny Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/fundamentally-strong-stocks-bse\">On BSE<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/solar-energy-stocks\">Solar Energy Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/psu-stocks-list\">PSU Stocks List<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-long-term-stocks-to-invest\">Long Term<\/a>&nbsp;<\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-penny-stocks-below-100-rs\">Below 100 Rs<\/a><\/td><td><a href=\"https:\/\/univest.in\/web-stories\/top-5-penny-stocks-under-re-1\">Top 5 Penny Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-fundamentally-strong-stocks\">For Long-Term<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-hospitality-stocks\">Hospitality Sector<\/a>&nbsp;<\/td><td><a href=\"https:\/\/univest.in\/blogs\/psu-stocks\">PSU Stocks in 2025<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-bike-stocks\">Best Bike Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-penny-stocks\">For 2025<\/a><\/td><td><a href=\"https:\/\/univest.in\/web-stories\/best-penny-stocks-to-invest-in-india\">Best Penny Stocks in India<\/a><\/td><td><a href=\"https:\/\/www.univest.in\/blogs\/penny-shares\">Penny Shares<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/hotel-stocks\">Hotel Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/top-government-stocks-in-india\">Government Stocks in 2024<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/top-liquor-stocks-in-india-2\">Best Liquor Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-stocks-below-100\">High-Growth Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-fundamentally-strong-penny-stocks\">For 2025<\/a><\/td><td><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-10-agriculture-stocks-in-india-2025\">Agriculture Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/government-stocks-list\">Government Stocks List<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-railway-stocks\">Best Railway Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/web-stories\/multibagger-stocks-under-rs-500-india-2024\">Under 500<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/penny-stocks\">Penny Stocks<\/a>&nbsp;<\/td><td><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-pharma-stocks\">Pharma Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/government-stocks-in-india\">Government Stocks in 2025<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/auto-sector-stocks\">Best Auto Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/top-10-multibagger-penny-stocks-for-2026\">For 2026<\/a><\/td><td><\/td><td><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-oil-and-gas-stocks\">Oil and Gas Sector<\/a><\/td><td><\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Univest_Screeners\"><\/span><strong>Univest Screeners<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Exclusive<\/strong><\/td><td><strong>Indices<\/strong><\/td><td><strong>Breakouts<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/short-term-verdict-buy\">Buy in the Short Term<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-smlcap-100\">Nifty Small Cap 100<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/daily-fresh-breakouts\">Daily Fresh Breakouts<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/long-term-verdict-buy\">Buy in the Long Term<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-midcap\">Nifty Midcap<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/weekly-breakouts\">Weekly Breakouts<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/fii-holding\">FII Holdings Change<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-bank\">Nifty Bank<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/oversold-stocks\">Oversold Stocks<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/golden-crossover\">Golden Crossover<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/sensex\">Sensex<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nearing-breakout\">Nearing Breakout<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/upcoming-dividents\">Upcoming Dividends<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-fin-service\">Nifty Fin Service<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/dii-holding\">DII Holdings Change<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/bankex\">Bankex<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/highest-dividend-paying-stocks\">High Dividend Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-midcap-100\">Nifty Mid Cap 100<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/top-results-to-watch\">Earnings Announced<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty50\">Nifty 50<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/fundamentally-strong-stocks\">Fundamentally Strong&nbsp;<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Top Gainers<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/top-losers\">Top Losers<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/low-debt-mid-cap\">Low Debt Mid Caps<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/cash-rich-small-cap\">Cash-Rich Small Caps<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/volume-shockers\">Volume Shockers<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/52-week-high\">52-Week High&nbsp;<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/52-week-low\">52-Week Low<\/a><\/td><td><\/td><td><\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explore_Webstories_on_Univest\"><\/span><strong>Explore Webstories on Univest&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/web-stories\/best-time-to-buy-dividend-stocks\/\">Best Time To Buy Dividend Stocks<\/a><\/p><p><a href=\"https:\/\/univest.in\/web-stories\/how-rbi-policies-affect-dividend-stocks\/\">How RBI Policies Affect Dividend Stocks<\/a><\/p><p><a href=\"https:\/\/univest.in\/web-stories\/can-dividend-stocks-beat-inflation\/\">Can Dividend Stocks Beat Inflation<\/a><\/p><p><a href=\"https:\/\/univest.in\/web-stories\/what-is-the-dividend-aristocrat-list\/\">What Is The Dividend Aristocrat List<\/a><\/p><p><a href=\"https:\/\/univest.in\/web-stories\/which-indian-psus-offer-the-best-dividends\/\">Which Indian Psus Offer The Best Dividends<\/a><\/p><p><a href=\"https:\/\/univest.in\/web-stories\/large-cap-vs-small-cap-dividend-stocks\/\">Large Cap Vs Small Cap Dividend Stocks<\/a><\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>The Invicta Diagnostic IPO is open for bidding from 1st December 2025 to 3rd December 2025. It is a bookbuilding IPO of \u20b928.12 crore and entirely a fresh issue worth \u20b933,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 8th December 2025.&nbsp; Invicta Diagnostic IPO Details&nbsp; The Invicta<\/p>\n","protected":false},"author":23,"featured_media":55308,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[3531],"class_list":["post-55307","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-invicta-diagnostic-ipo-gmp"],"metadata":{"_edit_lock":["1764158712:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:12:{s:81:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/11\/Invicta-Diagnostic-IPO-Review.jpg\";a:2:{s:2:\"id\";i:55309;s:11:\"source_type\";s:13:\"media-library\";}s:90:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/11\/Invicta-Diagnostic-IPO-Review-1024x536.jpg\";a:2:{s:2:\"id\";i:55309;s:11:\"source_type\";s:13:\"media-library\";}s:113:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review.jpg\";a:2:{s:2:\"id\";i:55309;s:11:\"source_type\";s:13:\"media-library\";}s:122:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172407\/Invicta-Diagnostic-IPO-Review-1024x536.jpg\";a:2:{s:2:\"id\";i:55309;s:11:\"source_type\";s:13:\"media-library\";}s:78:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/11\/Invicta-Diagnostic-Limited.jpg\";a:2:{s:2:\"id\";i:55310;s:11:\"source_type\";s:13:\"media-library\";}s:87:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/11\/Invicta-Diagnostic-Limited-1024x536.jpg\";a:2:{s:2:\"id\";i:55310;s:11:\"source_type\";s:13:\"media-library\";}s:110:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited.jpg\";a:2:{s:2:\"id\";i:55310;s:11:\"source_type\";s:13:\"media-library\";}s:119:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172506\/Invicta-Diagnostic-Limited-1024x536.jpg\";a:2:{s:2:\"id\";i:55310;s:11:\"source_type\";s:13:\"media-library\";}s:84:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/11\/Apply-for-Invicta-Diagnostic-IPO.jpg\";a:2:{s:2:\"id\";i:55311;s:11:\"source_type\";s:13:\"media-library\";}s:93:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/11\/Apply-for-Invicta-Diagnostic-IPO-1024x536.jpg\";a:2:{s:2:\"id\";i:55311;s:11:\"source_type\";s:13:\"media-library\";}s:116:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO.jpg\";a:2:{s:2:\"id\";i:55311;s:11:\"source_type\";s:13:\"media-library\";}s:125:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172720\/Apply-for-Invicta-Diagnostic-IPO-1024x536.jpg\";a:2:{s:2:\"id\";i:55311;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["91"],"rank_math_title":["Invicta Diagnostic IPO: Everything You Should Know About"],"rank_math_description":["Get Invicta Diagnostic IPO GMP, subscription details, price, lot size, and listing information. Should you park funds in the Invicta Diagnostic IPO in 2025? Read before applying for the IPO!\r\n"],"rank_math_focus_keyword":["Invicta Diagnostic IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["55308"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4819"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/invicta-diagnostic-ipo-gmp"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/26172238\/Invicta-Diagnostic-IPO.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=55307"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55307\/revisions"}],"predecessor-version":[{"id":55312,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55307\/revisions\/55312"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/55308"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=55307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=55307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=55307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}